We are live on ! Find out more

2,108 hedge funds and large institutions have $110B invested in Amgen in 2019 Q4 according to their latest regulatory filings, with 318 funds opening new positions, 669 increasing their positions, 839 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

397% more first-time investments, than exits

New positions opened: 318 | Existing positions closed: 64

81% more funds holding in top 10

Funds holding in top 10: 62112 (+50)

23% more capital invested

Capital invested by funds: $89.4B → $110B (+$20.6B)

12% more funds holding

Funds holding: 1,8842,108 (+224)

0.19% less ownership

Funds ownership: 77.17%76.98% (-0.19%)

20% less repeat investments, than reductions

Existing positions increased: 669 | Existing positions reduced: 839

21% less call options, than puts

Call options by funds: $1.49B | Put options by funds: $1.88B

Holders
2,108
Holders Change
+224
Holders Change %
+11.89%
% of All Funds
41.53%
Holding in Top 10
112
Holding in Top 10 Change
+50
Holding in Top 10 Change %
+80.65%
% of All Funds
2.21%
New
318
Increased
669
Reduced
839
Closed
64
Calls
$1.49B
Puts
$1.88B
Net Calls
-$387M
Net Calls Change
-$105M
Name Holding Trade Value Shares
Change
Change in
Stake
ISL
2126
Ingalls & Snyder LLC
New York
-$2.61M -13,474 Closed
SCA
2127
Stokes Capital Advisors
South Carolina
-$2.42M -12,531 Closed
FCMT
2128
Founders Capital Management (Texas)
Texas
-$2.27M -11,740 Closed
MC
2129
Machina Capital
France
-$2.13M -11,021 Closed
TCM
2130
Tuttle Capital Management
Connecticut
-$2.2M -10,526 Closed
VF
2131
Virtu Financial
New York
-$1.14M -5,881 Closed
Qube Research & Technologies (QRT)
2132
Qube Research & Technologies (QRT)
United Kingdom
-$1.05M -5,435 Closed
HSA
2133
Hussman Strategic Advisors
Maryland
-$1.02M -5,250 Closed
GCM
2134
Gladius Capital Management
Illinois
-$1.14M -5,170 Closed
LCM
2135
Landscape Capital Management
New Jersey
-$947K -4,892 Closed
MC
2136
Maverick Capital
Texas
-$941K -4,862 Closed
HF
2137
HRT Financial
New York
-$841K -4,348 Closed
TA
2138
Thor Advisors
New York
-$808K -4,178 Closed
OPCM
2139
Osborne Partners Capital Management
California
-$798K -4,125 Closed
VCM
2140
Virtue Capital Management
Tennessee
-$782K -4,040 Closed
SWP
2141
Strategic Wealth Partners
Ohio
-$117K -3,919 Closed
QT
2142
Quantamental Technologies
New York
-$693K -3,582 Closed
SCP
2143
Syntal Capital Partners
Texas
-$651K -3,532 Closed
KA
2144
Kovack Advisors
Florida
-$680K -3,515 Closed
VAS
2145
Vestmark Advisory Solutions
Massachusetts
-$609K -3,148 Closed
EMG
2146
ETF Managers Group
New Jersey
-$610K -3,128 Closed
EGM
2147
Engineers Gate Manager
New York
-$550K -2,840 Closed
LI
2148
Leap Investments
Illinois
-$406K -2,100 Closed
VSWA
2149
Vontobel Swiss Wealth Advisors
Switzerland
-$332K -1,715 Closed
GSWM
2150
Golden State Wealth Management
California
-$330K -1,708 Closed

AMGN Hedge Fund Activity: Q4 2019 in Review

2,108 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2019, worth a combined $110B — up 23% from $89.4B a quarter earlier.

Buyers outnumbered sellers: 318 funds opened new AMGN positions and 64 closed out — a net gain of 254 holders — while 669 added to existing stakes and 839 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $453M. The largest seller was Invesco, cutting an estimated $1.22B.

  • 2,108 institutional investors held Amgen (AMGN) as of Q4 2019, up from 1,884 in Q3 2019.
  • Funds reported $110B of Amgen stock for Q4 2019, up 23% quarter-over-quarter.
  • 318 funds opened new Amgen positions in Q4 2019 and 64 closed out, a net change of +254 holders.
  • The largest Amgen buyer in Q4 2019 was JP Morgan Chase, an estimated $453M added.
  • The largest Amgen seller in Q4 2019 was Invesco, an estimated $1.22B sold.

Based on aggregated 13F filings for Q4 2019.